Primus In News
Precision oncology gains ground as India clears targeted cancer therapies
25-12-2025
Nilaya Varma, Group CEO and Co-Founder,Primus Partners, highlights that the approvals represent a major step toward integrating outcome-based precision medicine into routine cancer care, with combination immunotherapies improving treatment outcomes for patient groups that previously had limited options.
Explore Related Insights
- After festival inventory buildup, two-wheeler dispatches fall in November
- GST on cars, two-wheelers: How are vehicles in different categories taxed? A deep dive
- India’s Textile MSMEs Hold Key To Hitting $100 Bn Export Target: Report
- MSME Budget 2022 Expectations: Three key areas experts say FM Nirmala Sitharaman must address
